Legislature(2017 - 2018)CAPITOL 106
02/28/2017 03:00 PM House HEALTH & SOCIAL SERVICES
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HB25 | |
| HB43 | |
| Presentation: Reducing Use of Emergency Department Services | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| *+ | HB 25 | TELECONFERENCED | |
| *+ | HB 43 | TELECONFERENCED | |
| + | TELECONFERENCED | ||
| + | TELECONFERENCED |
HB 25-INSURANCE COVERAGE FOR CONTRACEPTIVES
3:05:35
CHAIR SPOHNHOLZ announced that the first order of business would
be HOUSE BILL NO. 25, "An Act relating to insurance coverage for
contraceptives and related services; relating to medical
assistance coverage for contraceptives and related services; and
providing for an effective date."
3:05:44 PM
REPRESENTATIVE MATT CLAMAN, Alaska State Legislature, explained
that Alaskan women living and working in rural areas, in the
tourism industry, in the military, and on the North Slope did
not always have ready access to women's health services, and
faced additional barriers for obtaining access to family
planning options. He stated that women who currently used
hormonal contraceptives had to return to a pharmacy everyone to
three months to refill their prescriptions. He reported that
proposed HB 25 required health insurers to offer consumers the
option to receive a 12-month supply of hormonal contraception.
He declared that the women in his family supported the proposed
bill as improved access to contraceptives meant huge reductions
in unintended pregnancies. He added that unintended pregnancies
had a profound effect on the overall well-being of Alaskan
families, as it was associated with adverse maternal and child
health outcomes. Along with health concerns, unintended
pregnancy was a dramatic cost driver to public health programs.
He pointed out that it was often time consuming and inconvenient
to obtain a prescription for contraceptives every one to three
months. He offered his belief that, with the financial
challenges in the state, there should be discussion for ways to
reduce costs in both the short and long term. He declared that
proposed HB 25 offered these cost reductions, and that it made
sense for Alaska women and families.
3:07:34 PM
LIZZIE KUBITZ, Staff, Representative Matt Claman, Alaska State
Legislature, stated that proposed HB 25 mandated that health
care insurers provide coverage for a 12-month supply of
contraceptives. She pointed out that prescriptive
contraceptives included self-administered hormonal
contraceptives which did not require insertion or other
administration by a medical professional, namely oral
contraceptives, noting that this was discussed in Section 1 of
the proposed bill. She moved on to discuss the Sectional
Analysis of the bill [included in members' packets]. She said
that Section 1 also included a religious exemption and defined a
health care insurer as including a self-insured employer, such
as the State of Alaska. She moved on to discuss Section 2 of
the proposed bill, which directed the Department of Health and
Social Services to pay for the 12-month supply of prescription
contraceptives for eligible recipients of medical assistance.
She relayed that Section 3 of the proposed bill required the
Department of Health and Social Services to amend and submit for
federal approval a state plan for medical assistance coverage
consistent with Section 2. She explained that Section 4
provided a conditional effect of Section 2 and Sections 5 and 6
pertained to the effective dates.
MS. KUBITZ stated that one major premise behind the proposed
bill was that when women had greater access and availability to
contraceptives, there was a reduction of unintended pregnancies.
This resulted in a direct cost savings to the state, which was
reflected in the fiscal notes from Department of Health and
Social Services [included in members' packets]. She relayed
that one 2010 study in Alaska [included in members' packets]
found that 48 percent of all pregnancies in Alaska were
unintended. She added that an estimated 94.3 percent of these
unintended pregnancies were publicly funded. She reported that
Alaska spent $113.7 million on unintended pregnancies, of which
$70.8 million was paid for by the federal government and $42.9
million was paid for by the state. She pointed to an additional
study [included in members' packets] which studied 84,000 women
in California given 1 month, 3 month, or 12 month supplies of
oral contraceptives. The researchers of this study observed a
30 percent reduction in the odds of conceiving an unintended
pregnancy for those women given the 12 month supply of oral
contraceptives. This study also reported that the California
family planning program paid $99 more annually for women who
received three cycles and $44 more for women who received one
cycle than for women who received a year-long supply all at
once. She stated that this cost "was mostly due to the costs of
associated visits and the higher use of pregnancy tests among
women who received fewer cycles." She relayed that women who
received three cycles were almost twice as likely as women who
received the 12 month supply to visit a clinic to get a
pregnancy test. She noted that the proposed bill did not change
who was eligible for coverage, or the types of prescriptions
covered. The bill merely allowed women already receiving
coverage for prescription contraceptives to receive, if they so
choose, a 12 month prescription. She addressed concerns brought
forward by the Alaska National Federation of Independent
Business (NFIB) and by America's Health Insurance Plan (AHIP)
[included in members' packets]. As NFIB had concerns for
whether the proposed bill would include the state employee
health care plan, a definition of health care insurer which
included self-insured employers, such as the State of Alaska,
had been included in the proposed bill. She relayed that an
additional concern voiced by NFIB was for the cost burden of
supplying a 12 month supply of contraception at one time. She
pointed to multiple studies which had found that contraceptive
coverage did not raise insurance premiums, and that the
employers providing coverage could save money by avoiding the
costs associated with unintended pregnancy. She relayed that
the average commercial insurer payment for all maternal and
newborn care ranged from $18,000 to $28,000, whereas the average
hormonal birth control cost ranged from $100 to $600 per year.
She stated that prevention of one unintended pregnancy could
save an insurer at least $17,000, enough savings to pay for 29
additional years of contraception. She moved on to discuss the
concerns from AHIP [included in members' packets] which
concluded that the 12-month supply of contraceptives could
compromise patient safety as a result of decreased patient
visits to the prescribing physician. She pointed to research
which showed that birth control pills were safe and could be
safely prescribed based on a careful review of the patient's
medical history and blood pressure measurement. For most women,
no further examinations were necessary after the initial
prescription, unless the patient asked for a follow up during
the recommended yearly examination. She stated that the Centers
for Disease Control and Prevention (CDC) and the World Health
Organization (WHO) had presented a study in 2013 which
recommended dispensing a yearly supply of contraception with an
advisement to return at any time for discussion of side effects
or other problems, or to change the method. The study had
declared that no routine follow-up was required. She added
that, although AHIP had concerns for the efficacy of oral
contraceptives due to improper storage for a 12 month supply,
CDC had declared that oral contraceptives had a shelf life of
three to five years, dependent on the manufacturer, although
temperature and moisture could diminish this time frame. CDC
stated that most women who opted for a 12-month supply, and were
regular users of hormonal contraception, would know how to
properly store the medication. She addressed concerns for
waste, fraud, and abuse, and pointed out that research had found
that the average waste of a 12-month supply was for one cycle of
prescription contraceptives, and this was insignificant in
comparison to the other cost savings for fewer clinician and
pharmacy visits, and the associated costs for pregnancy.
Regarding fraud and abuse, although there were existing criminal
statutes for sale of hormonal contraceptives, this was not
anticipated as women would have greater access to the
contraceptives. She concluded by stating that proposed HB 25
would offer "huge advantages for Alaskan women, from eliminating
the inconvenience of refilling the prescription every one to
three months at a time, to the real inability of some Alaskan
women to make it to the clinic, hospital, or pharmacy to refill
that prescription at all." She pointed out that fisherwomen
sometimes spend three to four months out on a boat, women
attending college often have busy schedules balancing school and
a job, and women in Rural Alaska often had trouble making it to
a clinic or hospital due to a lack of transportation and limited
operating hours. She declared the HB 25 ensured that all
Alaskan women had the freedom to make decisions about their
futures.
3:16:28 PM
REPRESENTATIVE JOHNSTON shared that a three month supply of
birth control pills for her daughter was $800. She asked if
there was a discount for a 12 month supply.
MS. KUBITZ replied that her research had shown a cost savings
for buying in bulk.
REPRESENTATIVE JOHNSTON suggested more research for this.
3:17:40 PM
REPRESENTATIVE EDGMON pointed to the zero fiscal note.
MS. KUBITZ replied that there were two zero fiscal notes
[included in members' packets] provided by the Department of
Health and Social Services [OMB Component 242 and OMB Component
2007]. She relayed that one fiscal note projected anticipated
costs due to implementation of the proposed bill and the second
fiscal note detailed the cost savings.
3:18:35 PM
MARGARET BRODIE, Director, Director's Office, Division of Health
Care Services, Department of Health and Social Services,
addressed the Department of Health and Social Services (DHSS)
fiscal note labeled OMB Component 2007, and explained that this
fiscal note analyzed 7,940 female Medicaid recipients using oral
contraceptives. She estimated that 10 percent, 794 women, would
require duplication of services because the medication was not
effective, it was lost or stolen, or was not stored properly and
could lose its efficacy. She based the replacement value at $45
per month which was the national average drug acquisition cost
and the cost that the state used for its determination. She
shared that DHSS assumed that 75 percent of the women planned to
use oral contraceptives longer than 12 months, and that, as the
CDC cited a standard failure rate of 9 percent, this would
result in 540 unintended pregnancies. She reported that the
failure rate would decrease about 30 percent with a 12-month
supply of contraceptives, thereby lowering the failure rate to 7
percent. She pointed out that about 120 unintended pregnancies
could be avoided by using the 12-month contraception. She
stated that the estimated savings was based on the Medicaid
data, which reported that 5.28 births of the 120 avoided
pregnancies would have been complicated births, with the
remainder of births being non-complicated. She reported that
the cost factor for a complicated birth was $110,000, whereas
the cost factor for a non-complicated birth was $8,000. This
would result in a benefit cost savings to the Medicaid program
estimated to be $1,498,000, of which $562,000 would be
attributed to the Medicaid expansion population. She reported
an annual projected savings of $1,355,600. She added that this
was a conservative estimate, as some complicated births could
cost hundreds of thousands of dollars.
MS. BRODIE addressed the second fiscal note, OMB Component 242.
She offered her belief that this fiscal note could be removed,
as there was no state or federal statute that declared a need
for the department to go back and collect from the recipients.
3:24:41 PM
CHAIR SPOHNHOLZ expressed her agreement with saving the "money
in this particular area." She suggested that the savings would
be $1.2 - $1.3 million annually in overall Medicaid costs
related to contraception and unintended pregnancies.
MS. BRODIE expressed her agreement.
3:25:03 PM
REPRESENTATIVE SULLIVAN-LEONARD asked whether the proposed bill
would allow the state workers' health insurance program to offer
this benefit.
REPRESENTATIVE CLAMAN, in response, relayed that the intent of
the proposed bill was for this benefit to be included in the
state workers' health insurance plan.
REPRESENTATIVE SULLIVAN-LEONARD asked if there were other
medications that could be prescribed on a yearly basis, or was
this the first proposal for a year-long prescription.
MS. KUBITZ asked if Representative Sullivan-Leonard was asking
specifically about contraceptives. She stated that she was not
aware of any other medications that could have a year-long
prescription, as often many of these medications were controlled
substances.
REPRESENTATIVE SULLIVAN-LEONARD asked if any other prescription
drugs could be included in this format, pointing out that a 90-
day prescription was because a physician wanted to oversee the
interaction of the drug for the patient.
REPRESENTATIVE CLAMAN said that his office had not researched
this specific question. He recollected that certain mail-in
drug programs allowed for longer prescriptions, although it
depended on the medication.
CHAIR SPOHNHOLZ offered her belief that some other medications,
including some hormonal medications, were available on a yearly
prescription.
REPRESENTATIVE CLAMAN replied that he would look into this.
3:28:53 PM
CHAIR SPOHNHOLZ said that HB 25 would be held over.
| Document Name | Date/Time | Subjects |
|---|---|---|
| HB025 ver A 2.16.17.PDF |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Sponsor Statement 2.16.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Sectional Analysis ver A 2.16.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-Cost Savings Study 2.16.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-ADN Commentary 2.16.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-Guttmacher Alaska Statistics 2.16.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-Guttmacher Public Costs from Unintended Pregnancies 2.16.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-Letter Kachemak Bay Family Planning Clinic 2.23.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-Letter League of Women Voters Alaska 2.24.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-Unintended Pregnancies Study 2.16.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-Letter Planned Parenthood Votes Northwest & Hawaii 2.16.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-UCSF Study Newspaper Article 2.16.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-Letter Dr. Tina Tomsen 2.27.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Supporting Document-Support Emails 2.27.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Opposing Document-America's Health Insurance Plans 2.27.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Opposing Document-Letter NFIB 2.16.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Fiscal Note DHSS-Medicaid Services 2.28.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Fiscal Note DHSS-DHCS 2.28.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB025 Fiscal Note DCCED-DIO 2.28.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/9/2017 3:00:00 PM HHSS 4/6/2017 3:00:00 PM HHSS 4/11/2017 3:00:00 PM |
HB 25 |
| HB043 ver D 2.22.17.PDF |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB043 Sponsor Statement 2.22.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB043 Sectional Analysis ver D 2.22.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB043 Supporting Document - Legislative Map 2.22.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB043 Supporting Document - FDA Drug Review Process 2.22.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB043 Supporting Document - Clinical Trials in Alaska.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB043 Supporting Document - Goldwater Institute Fact Sheet 2.22.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB043 Supporting Document - Goldwater Institute Patient Stories 2.22.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB043 Supporting Document - Goldwater Institute Policy Report Summary 2.22.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB43 Supporting Document - Letters of Support 2.27.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB043 Fiscal Note DCCED--DCBPL 2.28.17.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| HB 43 Powerpoint Presentation.pdf |
HHSS 2/28/2017 3:00:00 PM HHSS 3/2/2017 3:00:00 PM HHSS 3/7/2017 3:00:00 PM |
HB 43 |
| AK ED Coordination Project from SB 74 to H HSS.pdf |
HHSS 2/28/2017 3:00:00 PM |